Loading clinical trials...
Loading clinical trials...
Evaluation of the Impact of the Administration of Single Dose of Ivermectin in the Early Phase of COVID-19 on the Time to Negativation of the SARS-COV-2 Viral Load Determinated by RT-PCR
Conditions
Interventions
Ivermectin
Locations
1
France
GHI Le Raincy Montfermeil
Montfermeil, France
Start Date
May 28, 2021
Primary Completion Date
May 1, 2022
Completion Date
June 1, 2022
Last Updated
September 10, 2021
Lead Sponsor
Raincy Montfermeil Hospital Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions